BioSpace News Archive

Establishment Labs Holdings Inc., a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – announced its one millionth Motiva® implant in market.

The Expert Access program for chronic lymphocytic leukemia (CLL), a first-of-its-kind collaboration, builds a “digital” bridge between underserved patient populations and the nation’s leading CLL physicians.

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that the European Medicines Agency (“EMA”) has agreed to the Company’s proposed Pediatric Investigation Plan (“PIP”) for omburtamab.

Screen Therapeutics LLC announces that is has formed a partnership with Immunaccel to focus on the discovery and development of next generation cancer immunotherapies.

Varian announced that its Board of Directors has scheduled the 2020 Annual Meeting of Stockholders for February 13, 2020 with a record date of December 16, 2019.

Johnson & Johnson announced that Hubert Joly, Executive Chairman of Best Buy Co., Inc, and Mark A. Weinberger, Former EY Global Chairman and CEO, have been appointed to its Board of Directors.

CooperCompanies announced financial results for the fiscal fourth quarter and full year ended October 31, 2019.

For makers, manufacturers, project managers, managers and data analysts, making time for training and upskilling employees and leaders could be a key competitive advantage in 2020

The first presentation is a sub-analysis of stimulation parameters that can determine the efficacy of VNS Therapy in patients with super-refractory status epilepticus

Kyriba Supply Chain Finance Technology Helps Scientist.com Make Early Payment Options Available to All R&D Suppliers